Literature DB >> 12112313

Protection against human papillomavirus type 16-E7 oncogene-induced tumorigenesis by in vivo expression of dominant-negative c-jun.

Matthew R Young1, Linda Farrell, Paul Lambert, Parirokh Awasthi, Nancy H Colburn.   

Abstract

Expression of the human papillomavirus (HPV) type 16 E6 and E7 gene products is a risk factor for human cervical carcinogenesis as well as skin and oral carcinogenesis. Expression of the HPV-16 E7 gene in mouse skin induces hyperplasia and enhances tumor promotion. Expression of dominant-negative c-jun (TAM67) in the mouse skin protects mice from 7,12-dimethylbenz[a]anthracene (DMBA)/12-O-tetradecanoylphorbol-13-acetate (TPA)-induced papillomagenesis without blocking mitogen-induced hyperproliferation. To determine the role of activator protein-1 (AP-1) in HPV-induced cancer, we crossed HPV-16 E7 mice with TAM67 mice and analyzed the effects of DMBA/TPA on tumor promotion. We showed that expression of TAM67 protected mice from HPV-16 E7-enhanced tumorigenesis, suggesting AP-1 as a target for prevention of HPV-induced cancer. Published 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12112313     DOI: 10.1002/mc.10050

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  15 in total

1.  c-Jun promotes whereas JunB inhibits epidermal neoplasia.

Authors:  Jane Y Jin; Hengning Ke; Russell P Hall; Jennifer Y Zhang
Journal:  J Invest Dermatol       Date:  2011-02-03       Impact factor: 8.551

2.  Identification and characterization of human LYPD6, a new member of the Ly-6 superfamily.

Authors:  Yifeng Zhang; Qingyu Lang; Jie Li; Fang Xie; Bo Wan; Long Yu
Journal:  Mol Biol Rep       Date:  2009-08-04       Impact factor: 2.316

Review 3.  Role of Zn2+ ions in host-virus interactions.

Authors:  Maciej Lazarczyk; Michel Favre
Journal:  J Virol       Date:  2008-09-10       Impact factor: 5.103

4.  Nothospondin, a new AP-1 inhibitory quassinoid from the Cameroonian plant Nothospondias staudtii.

Authors:  Thushara Diyabalanage; Ranjala Ratnayake; Jennifer A Wilson; Curtis J Henrich; John A Beutler; Nancy H Colburn; James B McMahon; Kirk R Gustafson
Journal:  Bioorg Med Chem Lett       Date:  2011-06-17       Impact factor: 2.823

5.  A novel aspartic proteinase-like gene expressed in stratified epithelia and squamous cell carcinoma of the skin.

Authors:  Verena Rhiemeier; Ute Breitenbach; Karl Hartmut Richter; Christoffer Gebhardt; Ingeborg Vogt; Bettina Hartenstein; Gerhard Fürstenberger; Cornelia Mauch; Jochen Hess; Peter Angel
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

6.  Targeting of Noncanonical Wnt5a Signaling by AP-1 Blocker Dominant-Negative Jun When It Inhibits Skin Carcinogenesis.

Authors:  Moon-Il Kang; Alyson R Baker; Christopher R Dextras; Stephanie M Cabarcas; Matthew R Young; Nancy H Colburn
Journal:  Genes Cancer       Date:  2012-01

7.  Suppressing AP1 factor signaling in the suprabasal epidermis produces a keratoderma phenotype.

Authors:  Ellen A Rorke; Gautam Adhikary; Christina A Young; Dennis R Roop; Richard L Eckert
Journal:  J Invest Dermatol       Date:  2014-08-22       Impact factor: 8.551

8.  Tumor necrosis factor receptor 1/c-Jun-NH2-kinase signaling promotes human neoplasia.

Authors:  Jennifer Y Zhang; Amy E Adams; Todd W Ridky; Shiying Tao; Paul A Khavari
Journal:  Cancer Res       Date:  2007-04-15       Impact factor: 12.701

Review 9.  Novel agents for the prevention of breast cancer: targeting transcription factors and signal transduction pathways.

Authors:  Qiang Shen; Powel H Brown
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-01       Impact factor: 2.673

10.  A selective small-molecule nuclear factor-kappaB inhibitor from a high-throughput cell-based assay for "activator protein-1 hits".

Authors:  Moon-Il Kang; Curtis J Henrich; Heidi R Bokesch; Kirk R Gustafson; James B McMahon; Alyson R Baker; Matthew R Young; Nancy H Colburn
Journal:  Mol Cancer Ther       Date:  2009-03-03       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.